Literature DB >> 12439833

Subjective emotional experience and cognitive impairment in drug-induced akathisia.

Jong-Hoon Kim1, Byung Chul Lee, Hyun-Jo Park, Yong Min Ahn, Ung Gu Kang, Yong Sik Kim.   

Abstract

The purpose of this study was to characterize the subjectively experienced symptoms and cognitive impairment associated with akathisia, which is among the most disabling adverse effects associated with antipsychotic drugs. While subjective experience is considered to be an integral part of akathisia, only a few studies have comprehensively investigated the specific contents of the subjective experiences or of the discomforts of patients with drug-induced akathisia. In addition, the precise relationship of akathisia to cognitive impairment, one of the main constituents of subjective experiences, is largely unknown. Forty-one stable and chronic schizophrenic patients, who were receiving maintenance antipsychotic treatment, were rated using the Barnes Akathisia Rating Scale (BARS) for drug-induced akathisia. Subjective experiences were evaluated using the Symptom Checklist-90-Revised (SCL-90-R), and cognitive function was assessed using the Wechsler Memory Scale (WMS). Analysis of covariance (ANCOVA) with relevant variables as covariates revealed that patients with akathisia (n = 17) had significantly higher scores on the depression subscale of the SCL-90-R than those without akathisia (n = 24). Patients with akathisia also had significantly lower scores on the mental control subtest of the WMS. Further analysis using ordinal logistic regression revealed that the depression subscale of SCL-90-R and the mental control subtest of WMS were significantly associated with the severity of akathisia. These results suggest that akathisia is significantly associated with depressive symptoms and attentional impairment, which reflects the complex nature of akathisia that includes motor, emotional, and cognitive aspects. Several methodological considerations and future directions are discussed. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12439833     DOI: 10.1053/comp.2002.35908

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  3 in total

1.  Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability.

Authors:  Ami Peljto; Ljubica Zamurovic; Milica Pejovic Milovancevic; Branko Aleksic; Dusica Lecic Tosevski; Toshiya Inada
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

2.  Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia.

Authors:  Ryohei Takada; Kazuhiko Yamamuro; Toshifumi Kishimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-02       Impact factor: 2.570

3.  Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia.

Authors:  Yeon-Jeong Shin; Yo-Han Joo; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-16       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.